A Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Chinese Healthy Adults
Clinical trial NCT05275660 · COMPLETED
Trial details
- NCT number
- NCT05275660
- Sponsor
- HiFiBiO Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-09
- Primary completion
- 2022-02-22
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.